Does living along the US-Mexico border affect the chances of survival among children with leukemia?

byWileyCredit: Unsplash/CC0 Public DomainResiding in border regions was linked with a higher risk of dying within five years among children with acute lymphoblastic leukemia, the most common typ

Updated on: January 04,2024

Does living along the US-Mexico border affect the chances of survival among children with leukemia?

byWileyCredit: Unsplash/CC0 Public DomainResiding in border regions was linked with a higher risk of dying within five years among children with acute lymphoblastic leukemia, the most common typ

Updated on:January 04,2024

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

Updated on: October 18,2024

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

Updated on:October 18,2024

Researchers apply fat cells to deliver drug to suppress tumor growth

by University of California, Los AngelesCredit: CC0 Public DomainResearchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor g

Updated on: March 08,2024

Researchers apply fat cells to deliver drug to suppress tumor growth

by University of California, Los AngelesCredit: CC0 Public DomainResearchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor g

Updated on:March 08,2024

Navigating the maze of cancer: How precision medicine unravels the unknown

by Simon L. April-Monn , Medical XpressPrecision medicine at the forefront. Guided by precision medicine, we pioneer tailored therapies for rare GEP-NENs, leveraging innovative tools to adapt treatmen

Updated on: March 30,2024

Navigating the maze of cancer: How precision medicine unravels the unknown

by Simon L. April-Monn , Medical XpressPrecision medicine at the forefront. Guided by precision medicine, we pioneer tailored therapies for rare GEP-NENs, leveraging innovative tools to adapt treatmen

Updated on:March 30,2024

Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

byPennsylvania State UniversityMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteImmunotherapies that mobilize a pati

Updated on: November 10,2024

Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

byPennsylvania State UniversityMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteImmunotherapies that mobilize a pati

Updated on:November 10,2024

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur

Updated on: April 28,2024

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur

Updated on:April 28,2024

Cell competition may explain cancer relapses, research suggests

byUT Southwestern Medical CenterCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0236A normal process called cell competition, in which healthy tissues eliminate unhealthy

Updated on: January 16,2024

Cell competition may explain cancer relapses, research suggests

byUT Southwestern Medical CenterCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0236A normal process called cell competition, in which healthy tissues eliminate unhealthy

Updated on:January 16,2024

Maximizing the potential of 3D-patient tumor avatars for next-generation precision oncology

by Terasaki Institute for Biomedical Innovation3D Patient Tumor Avatars (3D-PTAs) are part of a proposed integrative platform to provide optimal treatment selections for cancer patients. Such a platfo

Updated on: January 21,2024

Maximizing the potential of 3D-patient tumor avatars for next-generation precision oncology

by Terasaki Institute for Biomedical Innovation3D Patient Tumor Avatars (3D-PTAs) are part of a proposed integrative platform to provide optimal treatment selections for cancer patients. Such a platfo

Updated on:January 21,2024

AI facilitates breakthrough in sinonasal cancer diagnostics

byLudwig Maximilian University of MunichMethylation array for the determination of DNA modifications. Credit: Jurmeister et al.Although tumors in the nasal cavity and the paranasal sinus are con

Updated on: January 02,2024

AI facilitates breakthrough in sinonasal cancer diagnostics

byLudwig Maximilian University of MunichMethylation array for the determination of DNA modifications. Credit: Jurmeister et al.Although tumors in the nasal cavity and the paranasal sinus are con

Updated on:January 02,2024

Novel biomarker found in ovarian cancer patients can predict response to therapy

by University of Chicago Medical CenterTumor-specific expression of CT45 stimulates the patient's immune system to fight the cancer and improves the efficacy of platinum-based chemotherapy. C

Updated on: April 23,2024

Novel biomarker found in ovarian cancer patients can predict response to therapy

by University of Chicago Medical CenterTumor-specific expression of CT45 stimulates the patient's immune system to fight the cancer and improves the efficacy of platinum-based chemotherapy. C

Updated on:April 23,2024

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot

Updated on: August 03,2024

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot

Updated on:August 03,2024

ASCO: ovarian suppression + tamoxifen ups breast CA survival

(HealthDay)—The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer, according to a study published o

Updated on: March 30,2024

ASCO: ovarian suppression + tamoxifen ups breast CA survival

(HealthDay)—The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer, according to a study published o

Updated on:March 30,2024